These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
179 related articles for article (PubMed ID: 21277902)
41. IDO1 impairs NK cell cytotoxicity by decreasing NKG2D/NKG2DLs via promoting miR-18a. Zhang J; Han X; Hu X; Jin F; Gao Z; Yin L; Qin J; Yin F; Li C; Wang Y Mol Immunol; 2018 Nov; 103():144-155. PubMed ID: 30268986 [TBL] [Abstract][Full Text] [Related]
42. A chimeric receptor with NKG2D specificity enhances natural killer cell activation and killing of tumor cells. Chang YH; Connolly J; Shimasaki N; Mimura K; Kono K; Campana D Cancer Res; 2013 Mar; 73(6):1777-86. PubMed ID: 23302231 [TBL] [Abstract][Full Text] [Related]
43. Effect of Indoleamine 2,3-Dioxygenase Expressed in HTR-8/SVneo Cells on Decidual NK Cell Cytotoxicity. Ban Y; Zhao Y; Liu F; Dong B; Kong B; Qu X Am J Reprod Immunol; 2016 May; 75(5):519-28. PubMed ID: 26782048 [TBL] [Abstract][Full Text] [Related]
44. Melanoma cells inhibit natural killer cell function by modulating the expression of activating receptors and cytolytic activity. Pietra G; Manzini C; Rivara S; Vitale M; Cantoni C; Petretto A; Balsamo M; Conte R; Benelli R; Minghelli S; Solari N; Gualco M; Queirolo P; Moretta L; Mingari MC Cancer Res; 2012 Mar; 72(6):1407-15. PubMed ID: 22258454 [TBL] [Abstract][Full Text] [Related]
45. Critical role of the NKG2D receptor for NK cell-mediated control and immune escape of B-cell lymphoma. Belting L; Hömberg N; Przewoznik M; Brenner C; Riedel T; Flatley A; Polić B; Busch DH; Röcken M; Mocikat R Eur J Immunol; 2015 Sep; 45(9):2593-601. PubMed ID: 26151313 [TBL] [Abstract][Full Text] [Related]
46. Comprehensive analysis of NKG2D ligand expression and release in leukemia: implications for NKG2D-mediated NK cell responses. Hilpert J; Grosse-Hovest L; Grünebach F; Buechele C; Nuebling T; Raum T; Steinle A; Salih HR J Immunol; 2012 Aug; 189(3):1360-71. PubMed ID: 22730533 [TBL] [Abstract][Full Text] [Related]
47. Platelet-derived TGF-β1 mediates the down-modulation of NKG2D expression and may be responsible for impaired natural killer (NK) cytotoxicity in women with endometriosis. Guo SW; Du Y; Liu X Hum Reprod; 2016 Jul; 31(7):1462-74. PubMed ID: 27130956 [TBL] [Abstract][Full Text] [Related]
48. Indoleamine 2,3-dioxygenase suppresses the cytotoxicity of 1 NK cells in response to ectopic endometrial stromal cells in endometriosis. Liu XT; Sun HT; Zhang ZF; Shi RX; Liu LB; Yu JJ; Zhou WJ; Gu CJ; Yang SL; Liu YK; Yang HL; Xu FX; Li MQ Reproduction; 2018 Oct; 156(5):397-404. PubMed ID: 30087159 [TBL] [Abstract][Full Text] [Related]
49. B7-H1, which represses EBV-immortalized B cell killing by autologous T and NK cells, is oppositely regulated by c-Myc and EBV latency III program at both mRNA and secretory lysosome levels. Durand-Panteix S; Farhat M; Youlyouz-Marfak I; Rouaud P; Ouk-Martin C; David A; Faumont N; Feuillard J; Jayat-Vignoles C J Immunol; 2012 Jul; 189(1):181-90. PubMed ID: 22661084 [TBL] [Abstract][Full Text] [Related]
50. Peripheral Foxp3+ regulatory T cells and natural killer group 2, member D expression levels in natural killer cells of patients with colorectal cancer. Shen Y; Wang Q; Qi Y; Cui B; Zhang Z; Su J; Liu X; Lu C; Ye H; Ju Y; Lu Z Mol Med Rep; 2014 Aug; 10(2):977-82. PubMed ID: 24819058 [TBL] [Abstract][Full Text] [Related]
51. Elevated TGF-beta1 secretion and down-modulation of NKG2D underlies impaired NK cytotoxicity in cancer patients. Lee JC; Lee KM; Kim DW; Heo DS J Immunol; 2004 Jun; 172(12):7335-40. PubMed ID: 15187109 [TBL] [Abstract][Full Text] [Related]
52. Natural Killer Cell Activating Receptor NKG2D Is Involved in the Immunosuppressive Effects of Mycophenolate Mofetil and Hepatitis B Virus Infection. Dong S; Geng L; Shen MD; Zheng SS Am J Med Sci; 2015 May; 349(5):432-7. PubMed ID: 25828197 [TBL] [Abstract][Full Text] [Related]
53. Histamine reduces susceptibility to natural killer cells via down-regulation of NKG2D ligands on human monocytic leukaemia THP-1 cells. Nagai Y; Tanaka Y; Kuroishi T; Sato R; Endo Y; Sugawara S Immunology; 2012 May; 136(1):103-14. PubMed ID: 22304689 [TBL] [Abstract][Full Text] [Related]
54. Adipocytes affect castration-resistant prostate cancer cells to develop the resistance to cytotoxic action of NK cells with alterations of PD-L1/NKG2D ligand levels in tumor cells. Xu L; Shen M; Chen X; Zhu R; Yang DR; Tsai Y; Keng PC; Chen Y; Lee SO Prostate; 2018 Apr; 78(5):353-364. PubMed ID: 29330929 [TBL] [Abstract][Full Text] [Related]
56. Tumoral NKG2D alters cell cycle of acute myeloid leukemic cells and reduces NK cell-mediated immune surveillance. Tang M; Acheampong DO; Wang Y; Xie W; Wang M; Zhang J Immunol Res; 2016 Jun; 64(3):754-64. PubMed ID: 26740330 [TBL] [Abstract][Full Text] [Related]
57. Expansion of NK cells and reduction of NKG2D expression in chronic lymphocytic leukemia. Correlation with progressive disease. Huergo-Zapico L; Acebes-Huerta A; Gonzalez-Rodriguez AP; Contesti J; Gonzalez-García E; Payer AR; Villa-Alvarez M; Fernández-Guizán A; López-Soto A; Gonzalez S PLoS One; 2014; 9(10):e108326. PubMed ID: 25286418 [TBL] [Abstract][Full Text] [Related]
58. Prostate tumor-derived exosomes down-regulate NKG2D expression on natural killer cells and CD8+ T cells: mechanism of immune evasion. Lundholm M; Schröder M; Nagaeva O; Baranov V; Widmark A; Mincheva-Nilsson L; Wikström P PLoS One; 2014; 9(9):e108925. PubMed ID: 25268476 [TBL] [Abstract][Full Text] [Related]
59. "Acquired" NKG2D Ligand Stimulates NK Cell-mediated Tumor Immunosurveillance. Wang D; Gu X; Liu X; Liu X; Wang B; Lao F; Fang M J Immunother; 2019; 42(6):189-196. PubMed ID: 31145234 [TBL] [Abstract][Full Text] [Related]
60. Ganoderma lucidum stimulates NK cell cytotoxicity by inducing NKG2D/NCR activation and secretion of perforin and granulysin. Chang CJ; Chen YY; Lu CC; Lin CS; Martel J; Tsai SH; Ko YF; Huang TT; Ojcius DM; Young JD; Lai HC Innate Immun; 2014 Apr; 20(3):301-11. PubMed ID: 23803412 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]